According to the national medical insurance catalog for 2024 released today, jiangsu hengrui pharmaceuticals has four off-catalog pharmaceuticals included in the new medical insurance catalog: fumaric acid tepotin injection, otakonzole capsules, and huang-gliclazide metformin sustained-release tablets (I)/(II). However, several previously included off-catalog products such as abiraterone acetate tablets (II) are not listed in the 2024 medical insurance catalog.
恒瑞医药四款目录外品种进入医保目录
Jiangsu Hengrui Pharmaceuticals four varieties of products outside the catalog enter the medical insurance catalog.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated